LUCIE JONES: Open Payments
NPI 1376015735 · RUSTON, LA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,217 in 52 payments from 26 companies in 2025. Trend: 2023 $1,727 · 2024 $1,527 · 2025 $1,217
Food & beverage: $1,124Education: $93
| Company | Payments | Amount |
|---|---|---|
| Janssen Biotech, Inc. | 6 | $196 |
| Pharmacosmos Therapeutics Inc. | 5 | $113 |
| Stemline Therapeutics Inc. | 3 | $67 |
| Aveo Pharmaceuticals, Inc. | 3 | $66 |
| Takeda Pharmaceuticals U.S.A., Inc. | 3 | $65 |
| PharmaEssentia USA Corporation | 3 | $64 |
| Adaptive Biotechnologies Corporation | 2 | $58 |
| Novartis Pharmaceuticals Corporation | 3 | $52 |
| AstraZeneca Pharmaceuticals LP | 3 | $50 |
| Eisai Inc. | 2 | $47 |
Products named: ERLEADA, MONOFERRIC, Orserdu, FOTIVDA, BESREMI, ENHERTU, clonoSEQ, Lenvima.
Industry payments across LA — which companies pay providers there.
